CBL (gene): Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 45: Line 45:
[[Category:Signal transduction]]
[[Category:Signal transduction]]
[[Category:Ubiquitin-protein ligases]]
[[Category:Ubiquitin-protein ligases]]
{{No image}}
__NOINDEX__

Latest revision as of 05:42, 17 March 2025

CBL (Casitas B-lineage Lymphoma) is a gene that encodes a member of the Cbl family of E3 ubiquitin-protein ligases. CBL proteins play a crucial role in cell signaling and cancer development.

Function[edit]

The CBL gene is involved in the intracellular signaling pathways of many cell surface receptors involved with cellular growth, differentiation, and apoptosis. These receptors include EGFR, PDGFR, and c-Met. The protein encoded by the CBL gene functions as a negative regulator of many signaling pathways that start from these cell surface receptors.

Clinical significance[edit]

Mutations in the CBL gene have been associated with Noonan syndrome and myeloproliferative disorder, both of which are conditions that affect multiple systems of the body.

Structure[edit]

The CBL protein has a modular structure consisting of an N-terminal tyrosine kinase binding (TKB) domain, a linker region, a RING finger domain, a proline-rich region, and a C-terminal ubiquitin-associated (UBA) domain.

Interactions[edit]

CBL has been shown to interact with:

See also[edit]

References[edit]

<references />

External links[edit]










Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!